Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

✍ Scribed by R. A. Beveridge; John A. Miller; Arthur N. Kales; Richard A. Binder; Nicholas J. Robert; Janet Heisrath-Evans; Kathy Koczyk-Scripka; Steven Pashko; Michael J. Norgard; Harry M. Barnes; William R. Taylor; Keith A. Thompson; L. F. Smith; Winston M. Ueno; Robert F. Dobrzynski; Robert D. Warren; Daniel Katcher; Patrick J. Byrne; David M. Dunning; Stanley H. Winokur; Julian L. Lockey; Richard J. Cambareri; Thomas P. Butler; Robert J. Meister; John M. Fiegert

• Book ID: 105746957
• Publisher: Springer-Verlag
• Year: 1997
• Tongue: English
• Weight: 199 KB
• Volume: 5
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/pl00009894